Cantor Fitzgerald, Citigroup, and MarketBeat issued rating updates and price targets for Rigel Pharmaceuticals, Inc.
1 report, 1 independent
Updated 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald, Citigroup, and MarketBeat issued rating updates and price targets for Rigel Pharmaceuticals, Inc.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cantor Fitzgerald
American financial services company
-
Citigroup
American investment bank and financial services corporation
Related events
- MarketBeat provided consensus ratings while Cantor Fitzgerald and Jefferies Financial Group issued rating updates for Primoris Services Corporation.
- MarketBeat reported the stock's average rating while Citigroup reiterated a buy rating and Cantor Fitzgerald restated an overweight rating for Beta Technologies.
- MarketBeat provided average ratings and price targets while Cantor Fitzgerald cut Ouster's rating to neutral.
- Citigroup, Cantor Fitzgerald, and Raymond James Financial issued price target boosts for Xometry on November 4, 2026.
- Morgan Stanley dropped price target and Cantor Fitzgerald reduced price target on Regeneron Pharmaceuticals stock.